^
Association details:
Biomarker:No biomarker
Cancer:Acute Myelogenous Leukemia
Drug:clofarabine (DNA synthesis inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Acute Myeloid Leukemia (Age >/=18 years)...THERAPY FOR RELAPSED/REFRACTORY DISEASE...Aggressive therapy for appropriate patients...Clofarabine +/- Cytarabine +/- idarubicin